dansylsarcosine has been researched along with warfarin in 17 studies
| Studies (dansylsarcosine) | Trials (dansylsarcosine) | Recent Studies (post-2010) (dansylsarcosine) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 40 | 1 | 5 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | dansylsarcosine (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 9 (52.94) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buttar, D; Colclough, N; Gerhardt, S; MacFaul, PA; Maskos, K; Phillips, SD; Plowright, A; Steinbacher, S; Steuber, H; Tam, K; Whittamore, P | 1 |
| Bowmer, CJ; Panjehshahin, MR; Yates, MS | 3 |
| Bowmer, CJ; Mackay, D; Panjehshahin, MR | 1 |
| Brater, DC; Kirchner, KA; Voelker, JR | 1 |
| Hanano, M; Kurita, M; Sugimoto, T; Sugiyama, Y; Takikawa, H; Yoshida, H | 1 |
| Birkett, DJ; Wanwimolruk, S | 1 |
| Bowmer, CJ; Grigg, RE; McCormack, A; Munsey, T; Symonds, HW | 1 |
| Otagiri, M; Sakai, T; Takadate, A | 1 |
| Kunugi, S; Nishizawa, H; Tanaka, N | 1 |
| Bowmer, CJ; Rajaian, H; Symonds, HW | 1 |
| Gu, C; Lai, J; Nikolic, D; van Breemen, RB; Xu, X | 1 |
| Liang, Y; Ni, K; Tu, S; Wang, Y; Yu, JS; Zhong, W | 1 |
| Flarakos, J; Morand, KL; Vouros, P | 1 |
| Cohen, MP; Hud, E; Lautenslager, GT; Shearman, CW | 1 |
| Anraku, M; Chuang, VT; Kawai, K; Komatsu, T; Maruyama, T; Otagiri, M; Seo, H; Taguchi, K; Tanaka, R; Urata, Y; Yamasaki, K | 1 |
17 other study(ies) available for dansylsarcosine and warfarin
| Article | Year |
|---|---|
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Topics: Binding Sites; Crystallography, X-Ray; Drug Interactions; Humans; Pharmaceutical Preparations; Protein Binding; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence | 2010 |
A comparison of drug binding sites on mammalian albumins.
Topics: Albumins; Animals; Binding Sites; Binding, Competitive; Cattle; Dansyl Compounds; Diazepam; Dogs; Fatty Acids, Nonesterified; Fluorescence; Horses; Humans; Hydrogen-Ion Concentration; Kinetics; Nitrophenols; Phenylbutazone; Rats; Sarcosine; Sheep; Warfarin | 1992 |
Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
Topics: Binding Sites; Binding, Competitive; Dansyl Compounds; Diazepam; Fatty Acids; Fatty Acids, Unsaturated; Humans; In Vitro Techniques; Phenylbutazone; Protein Binding; Sarcosine; Serum Albumin; Structure-Activity Relationship; Valproic Acid; Warfarin | 1991 |
Analysis of the binding of fluorescent ligands to soluble proteins. Use of simultaneous non-linear least squares regression to obtain estimates of binding parameters.
Topics: Albumins; Anilino Naphthalenesulfonates; Dansyl Compounds; Fluorescence; Fluorescent Dyes; Humans; Kinetics; Ligands; Linear Models; Models, Biological; Proteins; Regression Analysis; Sarcosine; Software; Warfarin | 1991 |
Binding inhibitors restore furosemide potency in tubule fluid containing albumin.
Topics: Albumins; Animals; Binding Sites; Binding, Competitive; Body Fluids; Dansyl Compounds; Drug Tolerance; Furosemide; Kidney Tubules, Distal; Male; Nephrotic Syndrome; Perfusion; Protein Binding; Rats; Rats, Inbred Strains; Sarcosine; Sulfisoxazole; Warfarin | 1991 |
A novel binding site for bile acids on human serum albumin.
Topics: Bile Acids and Salts; Bilirubin; Binding Sites; Coumarins; Dansyl Compounds; Fatty Acids, Unsaturated; Fluorescent Dyes; Glucuronates; Humans; Kinetics; Oleic Acid; Oleic Acids; Sarcosine; Serum Albumin | 1987 |
A pitfall in the use of double-reciprocal plots to estimate the intrinsic molar fluorescence of ligands bound to albumin.
Topics: Albumins; Anilino Naphthalenesulfonates; Dansyl Compounds; Fluorescence; Protein Binding; Sarcosine; Warfarin | 1989 |
The effects of N-B transition of human serum albumin on the specific drug-binding sites.
Topics: Binding Sites; Calcium; Chlorides; Dansyl Compounds; Humans; Hydrogen-Ion Concentration; Oleic Acid; Oleic Acids; Protein Binding; Protein Conformation; Sarcosine; Serum Albumin; Warfarin | 1982 |
Binding of sulphamethazine to pig plasma proteins and albumin.
Topics: Analysis of Variance; Animals; Anti-Infective Agents; Binding Sites; Blood Proteins; Dansyl Compounds; Fluorescent Dyes; Hydrogen-Ion Concentration; Male; Protein Binding; Sarcosine; Serum Albumin; Sulfamethazine; Swine; Thermodynamics; Warfarin | 1996 |
Characterization of binding site of uremic toxins on human serum albumin.
Topics: Binding Sites; Dansyl Compounds; Furans; Hippurates; Humans; Indoleacetic Acids; Indoles; Propionates; Sarcosine; Serum Albumin; Uremia; Warfarin | 1995 |
Structure of pressure-induced denatured state of human serum albumin: a comparison with the intermediate in urea-induced denaturation.
Topics: Bilirubin; Circular Dichroism; Dansyl Compounds; Fluorescent Dyes; Humans; Pressure; Protein Conformation; Protein Denaturation; Sarcosine; Serum Albumin; Spectrometry, Fluorescence; Urea; Warfarin | 1997 |
Drug binding sites on chicken albumin: a comparison to human albumin.
Topics: Albumins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Apazone; Binding Sites; Chickens; Dansyl Compounds; Humans; Hydrogen-Ion Concentration; Hydrolysis; Ligands; Nitrophenols; Sarcosine; Species Specificity; Warfarin | 1997 |
Assays of ligand-human serum albumin binding using pulsed ultrafiltration and liquid chromatography-mass spectrometry.
Topics: Chromatography, Liquid; Dansyl Compounds; Humans; Ligands; Mass Spectrometry; Sarcosine; Serum Albumin; Ultrafiltration; Warfarin | 1999 |
The interaction of human serum albumin with a novel antidiabetic agent--SU-118.
Topics: Binding Sites; Coumarins; Dansyl Compounds; Desulfurococcaceae; Fluorescent Dyes; Humans; Hypoglycemic Agents; Microscopy, Fluorescence; Protein Binding; Sarcosine; Serum Albumin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Sulfonylurea Compounds; Thermodynamics; Tryptophan | 2004 |
High-throughput solution-based medicinal library screening against human serum albumin.
Topics: Acecainide; beta-Lactams; Chromatography, Gel; Chromatography, Liquid; Combinatorial Chemistry Techniques; Dansyl Compounds; Humans; Imipramine; Indomethacin; Pharmaceutical Preparations; Protein Binding; Quinidine; Reproducibility of Results; Sarcosine; Serum Albumin; Tandem Mass Spectrometry; Tryptophan; Warfarin | 2005 |
Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin.
Topics: Dansyl Compounds; Fatty Acids, Unsaturated; Fluorescence; Glycosylation; Humans; Linoleic Acid; Oleic Acid; Palmitic Acid; Sarcosine; Serum Albumin; Warfarin | 2011 |
Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs.
Topics: Animals; Binding Sites; Dansyl Compounds; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dimerization; Drug Carriers; Fatty Acids; Fluorescent Dyes; Half-Life; Humans; Hypoglycemic Agents; Male; Maleimides; Permeability; Plasma; Protein Binding; Rats; Rats, Sprague-Dawley; Sarcosine; Serum Albumin; Warfarin | 2015 |